Summary Box: Medtronic 4th-quarter earnings

GAIN ON RIVAL'S PAIN: Medtronic said its fourth-quarter profit growth was helped by higher sales of implantable defibrillators after rival Boston Scientific suspended U.S. sales of those devices for a month.

NET INCOME BOOST: Medtronic earned $954 million, or 86 cents per share, in the last quarter of 2009, up from $103 million, or 9 cents per share, a year ago. The prior period's results were weighed down by a large license payment.

BACK PROBLEMS: Medtronic continued to report lackluster sales of its spinal implants, with revenue edging down 2 percent to $880 million in the quarter. Company executives also said pricing competition has squeezed profit margins.

GAIN ON RIVAL'S PAIN: Medtronic said its fourth-quarter profit growth was helped by higher sales of implantable defibrillators after rival Boston Scientific suspended U.S. sales of those devices for a month.NET INCOME BOOST: Medtronic earned $954 million, or 86 cents per share, in the last quarter...

Disable Cookies per browser:

Note: If you are using a browser that is not listed here, please do a quick internet search on how to block cookies and tracking for your specific browser.

This website uses cookies to ensure you get the best user experience. If you agree to accept these cookies, confirm by clicking the "Ok, I Agree" button. For instructions on how to block cookies from this site, please click the "Give Me More Info" button.